Home Page

2019 Voxmedia HFSA Pgm Image

Management of LDL-Cholesterol:
Taking the Next Steps

Saturday, November 16, 2019

                          Symposium: 6:30PM - 8:00PM

                          Venue:  Philadelphia Marriott Downtown
                                        Liberty Ballroom A-B, 3rd Floor
                                        1201 Market St.
                                        Philadelphia, Pennsylvania

                          Faculty: James Underberg, MD, MS (Chair);
                                        Christie Ballantyne, MD;
                                        Steven Nissen, MD.

Registration for this program is now closed.

This event is not part of the official Scientific Sessions 2019 as planned by the AHA Committee on Scientific Sessions Programming.

Accredited Sponsor:
Voxmedia, LLC

This is a complimentary event. Registration does not guarantee seating. This event is designed for the education of physicians and improvement in the care of patients. Priority is given to clinicians. We are unable to accommodate guests.

Program Overview:

LDL-cholesterol (LDL-C) is a central focus of cardiovascular risk reduction. Unfortunately, many individuals with elevated LDL-C are not achieving treatment goals despite the use of guideline-recommended statin therapy. This includes individuals who have a suboptimal response to recommended intensity of statin therapy, and also those who are unable to tolerate the recommended statin intensity. Furthermore, some patients are not able to tolerate any dose of a statin. Even if patients initiate treatment with statins, lack of adherence to statin therapy is a significant concern. Patients with suboptimal LDL-C levels are at increased risk of major adverse cardiovascular events. In this educational initiative, lipid experts will address the clinical problems of inadequate response to statin therapy, statin adherence, and statin intolerance. Best practices to address these issues will be identified, and the clinical profiles of emerging non-statin, LDL-C-lowering therapies will be described.

Educational Objectives: 

Upon completion of this activity, attendees should be able to:

  • Indicate that LDL-C remains a central focus of cardiovascular risk reduction.
  • Recognize that adherence to statin therapy is a significant clinical problem.
  • Identify patients at risk for statin intolerance and discuss current and emerging treatment approaches.
  • Describe the clinical profiles of emerging non-statin, LDL-C-lowering therapies for treatment of patients requiring additional lowering of LDL-C.

Target Audience:
This educational activity is intended for cardiovascular clinicians.

Educational Grant:
Voxmedia gratefully acknowledges the educational grant provided by Esperion Therapeutics, Inc.

Accreditation and Credit Designation Statements:

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Voxmedia LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 CreditsTMthrough its reciprocity agreements. The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 CreditsTMfrom organizations accredited by the ACCME.

Disclosure Statement:

It is the policy of Voxmedia to ensure fair-balance, independence, objectivity, and scientific rigor in all directly or jointly sponsored educational activities. All prospective faculty are required to disclose any significant financial, other interest or relationship (1) with any commercial interest producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients AND (2) with any commercial supporters prior to participating in the planning of an activity or developing content. Only then may faculty receive approval to participate, and are expected to contribute evidence-based material and information. Faculty are required to indicate areas of their presentation that are based on professional opinion vs. guidelines, meta-analysis etc. All information submitted will be peer-reviewed.

Americans with Disabilities Act Voxmedia fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant of this activity is in need of accommodation, please call and/or submit in writing to: Voxmedia, 454 Morris Avenue, Springfield, New Jersey 07081 USA; Phone: 973-467-0500.